ABOUT US
20/20 Onsite is a healthcare services company providing clinical trial solutions that transform the delivery of vision care by radically improving patient access through state-of-the-art Mobile Vision Clinics. 20/20 Onsite's integrated point-of-need service delivery platform has taken high-value eye assessment services directly to patients at work, at school, in neighborhoods, and at clinical research sites. During the pandemic, 20/20 Onsite began bringing ophthalmic assessments to patients in clinical trials or post-marketing safety surveillance programs nationwide, increasing access to clinical research. 20/20 Onsite enables and accelerates fundamental trends toward the consumerization of care and the decentralization of clinical trials.
20/20 Onsite has served over 85,000 patients, including 22 clinical trials, met 100% of screening timelines across operations, and consistently reports patient NPS scores of over 94.
FEATURED ARTICLES
-
Fluctuations in eye pressure measurements can jeopardize trial results. Learn how standardized execution and equipment calibration protect data integrity and regulatory credibility.
-
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
-
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
Sponsors are addressing patient dropout rates by shifting from reactive troubleshooting to proactive protocol designs that minimize participant burden.
-
Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.
-
Learn how expert site initiation visit (SIV) planning masters complex endpoints like OCT and BCVA, eliminates data variability, and prevents the costly need for trial rescue.
-
Quickly assess clinical trial risks by evaluating site impact, patient safety, and budget tradeoffs. Turn high-pressure rescue scenarios into clear, actionable paths for your research team.
-
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
-
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
-
Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.
CONTACT INFORMATION
20/20 Onsite
29 Garden Street
Everett, MA 02149
UNITED STATES
Phone: 617-812-9453
Contact: Jessica McKenzie, Vice President, Life Sciences